Related Experiment Video
Updated: Aug 14, 2026

Controlled Microfluidic Environment for Dynamic Investigation of Red Blood Cell Aggregation
Published on: June 4, 2015
Red cell and hemorheological changes in multiple sclerosis
Abstract:
Blood rheology in multiple sclerosis (MS) was investigated in 15 subjects with varying degrees of locomotor difficulties who were members of the local MS Society. Control data were obtained from blood samples from 25 male and 25 female normal blood donors. Whole blood viscosity was measured and blood filterability was assessed. Six MS females provided blood samples for scanning electron microscopy. Erythrocyte membrane fatty acids and phospholipids were assayed. Whole blood viscosity in MS females was higher than controls at 3 of 4 shear rates (p less than 0.001) but in MS males blood viscosity was higher only at shear rate of 1.0 s-1 (p less than 0.05). MS erythrocyte filtration rates were significantly lower than controls (p less than 0.001). Leucocyte counts in MS were greater than controls both in males (p less than 0.01) and females (p less than 0.001). MS erythrocyte morphology was greatly different from controls (p less than 0.0001) and erythrocyte membranes contained less sphingomyelin than controls (p less than 0.01) but more phosphatidylinositol plus phosphatidylserine (p less than 0.02). We conclude that, because our findings indicate an identifiable and potentially correctable abnormality, it is possible to envisage an inhibition of the progressive nature of MS, with the hope of a better prognosis for patients.
Insights
Multiple sclerosis (MS) patients show altered blood viscosity and erythrocyte filtration. These findings suggest potential therapeutic targets for improving MS prognosis.
Area of Science:
- Hematology
- Neuroimmunology
- Biophysics
Background:
- Multiple sclerosis (MS) is a chronic neurological disease.
- Understanding blood rheology in MS is crucial for disease management.
Purpose of the Study:
- To investigate blood rheology differences in multiple sclerosis (MS) patients compared to healthy controls.
- To identify potential biomarkers and therapeutic targets in MS.
Main Methods:
- Whole blood viscosity and erythrocyte filtration were measured.
- Scanning electron microscopy and erythrocyte membrane analysis were performed.
- Leukocyte counts were compared between MS patients and controls.
Main Results:
- MS patients exhibited higher whole blood viscosity and lower erythrocyte filtration rates.
- Significant differences in erythrocyte morphology and membrane composition were observed in MS.
- Elevated leukocyte counts were found in MS patients.
Conclusions:
- Identifiable and potentially correctable abnormalities in blood rheology exist in MS.
- These findings offer hope for inhibiting MS progression and improving patient prognosis.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Regulation of Hematopoietic Stem Cells
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Hemorrhagic Stroke ll: Pathophysiology
Multiple Sclerosis l: Introduction

